PE-backed Quest buys Summit Pharmaceuticals/Alliance Labs

Quest, which is backed by Promus Equity Partners, has acquired Summit Pharmaceuticals/Alliance Labs, a maker of mini-enema laxatives.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this